The WMIC produces medicines-related guidance for healthcare professionals across NHS Wales.
These pages are currently under development and we would welcome feedback on them.
Understanding ranibizumab biosimilar: Ongavia®▼
Information is provided to support the introduction of Ongavia®▼(ranibizumab) biosimilar by healthcare professionals involved in the procurement, storage, supply and administration of Ongavia®▼such as Ophthalmology medical and nursing specialists, and pharmacy teams.
18 Jul 22 Published.